Bill Snyder
-
Noted science writer Zimmer set for next Discovery Lecture
Award-winning New York Times science writer and columnist Carl Zimmer will deliver the next Flexner Discovery Lecture on Thursday, Oct. 3, on setting science “right” when it goes “wrong.” Read MoreSep 26, 2013
-
Best-selling author Warner kicks off Conte Center events
Judith Warner, award-winning author of the New York Times bestseller “Perfect Madness: Motherhood in the Age of Anxiety,” will speak at Nashville’s Adventure Science Center at 7 p.m., Tuesday, Oct. 8. Read MoreSep 26, 2013
-
Grant broadens graduate, postdoc training programs
Vanderbilt University Medical Center has received a five-year, $1.2 million grant from the National Institutes of Health (NIH) to develop “bold and innovative approaches to broaden graduate and postdoctoral training.” Read MoreSep 26, 2013
-
Twelfth annual Vanderbilt Research Retreat set for Oct. 4
The Vanderbilt community is invited to attend the 12th annual Research Retreat, a showcase of cutting-edge biomedical science by Vanderbilt faculty members and trainees. Read MoreSep 24, 2013
-
VU study brings genome’s ‘dark matter’ into light
Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer. Read MoreSep 19, 2013
-
Learning expert Merzenich set for Discovery Lecture
Michael Merzenich, Ph.D., author of “Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life,” will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Sept. 26, in 208 Light Hall. Read MoreSep 19, 2013
-
Transporter linked to autism risk
Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD). Read MoreSep 19, 2013
-
Two named to National Academies’ advisory board
Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism. Read MoreSep 12, 2013
-
Nobel laureate Beutler to speak at VU Sept. 23
Nobel laureate Bruce Beutler, M.D., will discuss his research on innate immunity during a noon seminar Monday, Sept. 23, in 208 Light Hall. Read MoreSep 12, 2013
-
Discovery Lecture explores brain’s addiction mechanisms
Nora Volkow, M.D., director of the National Institute on Drug Abuse, delivers last week’s Discovery Lecture. Since she was a medical student in her native Mexico, Nora Volkow, M.D., has been fascinated by drug addiction. “It really did not make any sense … that someone would be… Read MoreSep 5, 2013
-
‘Simple Beginnings’ ceremony welcomes 98 doctoral students
Alexander Sevy dons his white coat with the help of Kathleen Gould, Ph.D., at the fourth annual “Simple Beginnings” ceremony for new doctoral students. (Photo by Anne Rayner) Vanderbilt University welcomed 98 new doctoral students into its scientific community last week during the fourth annual “Simple Beginnings”… Read MoreSep 5, 2013
-
Basic science training grants hit NIH funding ‘grand slam’
When it comes to government funding of basic science training programs for graduate students and postdoctoral fellows, Vanderbilt University Medical Center hit a grand slam this year, officials said. Read MoreAug 29, 2013
-
Addiction science expert Volkow to speak Aug. 29
Nora Volkow, M.D., director of the National Institute on Drug Abuse, will begin the 2013-2014 Flexner Discovery Lecture Series next Thursday, Aug. 29, with a discussion of “Advances in Addiction Science.” Read MoreAug 22, 2013
-
VU investigators land ‘bridge grants’ from hematology society
Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts. Read MoreAug 22, 2013
-
$5.2M NIH grant bolsters colorectal cancer research
Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Read MoreAug 15, 2013
-
Transplant drug added to PREDICT program
Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection. Read MoreAug 15, 2013
-
Oxidative stress in autism
A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care. Read MoreAug 14, 2013
-
Nuclear shield against cell death
The protein SARM appears to protect cells from inflammation-driven death by stabilizing the nuclear laminin scaffold. Read MoreAug 8, 2013
-
Vanderbilt scientists discover potential new way to treat anxiety
Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week. Read MoreAug 5, 2013
-
Data management tool developed at VU sees global growth
The number of researchers and institutions worldwide using a Vanderbilt University-developed Web application to collect and manage their data has about doubled in the past year. Read MoreJul 18, 2013